Wed, Apr 23, 2014, 11:26 AM EDT - U.S. Markets close in 4 hrs 34 mins

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • chrt13 chrt13 Jul 25, 2007 6:46 PM Flag

    How my 100K investment in Pfizer is faring

     

    Starting point - 100,000 on 11/17/04 with the stock at $27.99. Low-water mark was $31,650 with the stock at a 98-month closing low of $20.60 on 12/9/05. The high point before this calendar year was $181,645 with the stock at $28.47 on 9/20/06.

    12/01 - 180,300 ($27.86)
    12/04 - 098,985 ($24.90) Torcetrapib failure
    12/20 - 136,230 ($26.21)
    12/29 - 128,925 ($25.90) Year-end 2006 close
    01/19 - 157,645 ($27.22) Session before Q4-06 earnings
    01/22 - 155,030 ($26.95) Q4-06 earnings released
    01/23 - 143,400 ($26.37)
    01/24 - 154,145 ($26.82)
    01/29 - 136,040 ($26.06)
    02/05 - 156,390 ($26.88)
    02/07 - 154,240 ($26.52) Ex-dividend 29 cents
    02/12 - 147,595 ($26.22)
    02/14 - 156,970 ($26.58)
    02/26 - 139,465 ($25.84)
    02/27 - 119,990 ($25.14) 416-point Dow plunge
    03/05 - 106,875 ($24.70) Closing low for 2007
    03/09 - 127,390 ($25.41)
    03/14 - 110,045 ($24.86) Successful test of 3/5 low
    03/21 - 140,440 ($25.85)
    03/28 - 120,865 ($25.18) Last session before 10% Dow gain
    04/20 - 171,060 ($26.97) Session before Q1-07 earnings
    04/23 - 153,435 ($26.35 Q1-07 earnings released
    04/24 - 148,870 ($26.15)
    05/07 - 181,330 ($27.38)
    05/09 - 182,725 ($27.16) Ex-dividend 29 cents
    05/10 - 173,120 ($26.80)
    06/01 - 196,065 ($27.68) Closing high for 2007 to date
    06/07 - 157,150 ($26.29) Dow falls 410 points in 3 sessions
    06/08 - 164,855 ($26.52)
    06/12 - 154,950 ($26.11)
    06/15 - 166,485 ($26.47)
    06/20 - 142,370 ($25.71)
    06/21 - 150,580 ($25.92)
    06/25 - 133,045 ($25.40) Height of hedge fund jitters
    07/05 - 148,130 ($25.90)
    07/11 - 133,885 ($25.45)
    07/16 - 153,140 ($26.08)
    07/17 - 152,000 ($25.96) Session before Q2 earnings
    07/18 - 121,690 ($25.13) Q2 earnings released
    07/24 - 114,550 ($24.89)
    07.25 - 110,640 ($24.78)


    For 2007 to date, the investment is down by 14.2% ($18,285) on a 2.1% decrease in the stock price including two 29-cent dividends.

    This investment is highly-leveraged to the point where I earn about six times what a buy-and-hold investor does up to $27.50. Between $27.51 and $30, I earn about three-and-a-half times what a buy-and-hold investor does. However, I still earn a decent return if the stock does nothing at all (20 to 25% earned per year) and I only get hurt somewhat should the stock really tank. In that case, I would lose over time something like two-and-a-half times that of a buy-and-hold investor. That would be on paper. In order to truly be saddled with that loss, the stock would have to stay down for over a year.

    My current breakeven is down to $24.45. Every point between $25.00 and $27.50 means about 40K over time. Over $27.50, every point means about 24K.

    With the stock at the same closing price as it is now ($24.78) at January options expiration, I would be able to cash out for 117K.

    If Pfizer is $27.50 at January expiration, I would likely be able to cash out for 226K factoring in the effects of remaining rollovers.

    If Pfizer is $30 at January expiration, the cashout value would grow to 286K.

    If Pfizer is $31 in mid-January 2009, I will be able to cash out for at least 350K.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • " I never mess with that sort of thing in Los Angeles"

      You should mess around with that sort of thing on Wall Street either charty.

      You got Royaly Fucked Today!

    • Charty:

      I know it is painful, but how is your 100K investment doing at the end of today's close? Good case of someone falling in love in a underperforming stock.

    • Any travesties coming? Don't ask chartness!

      *************************************************
      Re: Milo, your bet's looking good! Already 65% of the way 13-Jun-07 08:25 pm

      There's no "traditionally" about it. The past three years it just so happens there were major travesties the second half (adverse Celebrex test in 2004, the yanking of estimates in 2005 and Torcetrapib failure in 2006).

      There's nothing apparent in the way of travesties in 2007. No optimistic forecasts and no huge drugs under development that could fail. Any travesty this year would have to come completely out of the blue. There would be little reason for an investor to expect any such thing.

      You saw the lows this year on March 5 with the $24.70 close. Nothing resembling that will be seen. EVER!

      chrt13
      ****************************************************

      Got that? "Nothing resembling that will be seen. EVER!"

    • It was not a good day for Mr. Monk either, as my gains for the year are now only 3.2%

      But I'm still beating Mr. Chartness's ass badly!

      If I beat Mr. Chartness for the full-year, can I have him as a pet?

 
PFE
30.85-0.150(-0.48%)11:26 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.